亚洲 · 区域市场 · Vietnam Investment Review

Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology

来源：Vietnam Investment Review · 越南 9 小时前

Sichuan Kelun-Biotech Biopharmaceutical published overall survival analysis from its Phase III OptiTROP-Breast01 study in Annals of Oncology during the ESMO Congress in Madrid.

在 Vietnam Investment Review 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (vir.com.vn)

Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology

推荐阅读

ทรัมป์เดือด! เตรียมแบนคำว่า AI ให้ใช้คำว่า SI

Max Financial Services Q2: Value of new business rises to ₹734 crore, total APE at ₹2,716 crore

United Breweries Q2 results: Profit jumps 190%, revenue rises 24% as premium beer volumes surge; Kingfisher sales up 44%

SpiceJet's domestic market share falls below Star Air for the first time

บอร์ด OR ตั้ง “นิสิต พงษ์วุฒิประพันธ์” นั่งซีอีโอคนใหม่แทน “ม.ล.ปีกทอง”

Anthropic’s IPO filing lifts markets but raises AI safety fears. What should S’pore investors know?

Kelun Biotech publishes sac TMT breast cancer study in Annals of Oncology

分享

推荐阅读

ทรัมป์เดือด! เตรียมแบนคำว่า AI ให้ใช้คำว่า SI

Max Financial Services Q2: Value of new business rises to ₹734 crore, total APE at ₹2,716 crore

United Breweries Q2 results: Profit jumps 190%, revenue rises 24% as premium beer volumes surge; Kingfisher sales up 44%

SpiceJet's domestic market share falls below Star Air for the first time

บอร์ด OR ตั้ง “นิสิต พงษ์วุฒิประพันธ์” นั่งซีอีโอคนใหม่แทน “ม.ล.ปีกทอง”

Anthropic’s IPO filing lifts markets but raises AI safety fears. What should S’pore investors know?